Delusional beliefs and their behavioral consequences are predominant symptoms in patients with psychosis and play an important role in the treatment. Delusional beliefs are a multidimensional concept which can be divided into three components: distress, preoccupation and conviction of delusions. These can be measured using Peters delusions inventory (PDI-21). We question, whether changes in delusional beliefs over time during treatment measured with the PDI-21 can predict changes in belief flexibility measured with the Maudsley assessment of delusions schedule (MADS). We used a group of patients from a randomized controlled trial for a cognitive intervention for psychosis or psychotic symptoms. Aside standard treatment for psychosis, half of the patients took part in a group treatment “Michael’s game”. Patients were assessed at baseline (T1), at 3 months (T2), and at 9 months (T3). We measured delusional beliefs using PDI-21 and belief flexibility with the MADS. One hundred seventy-two patients were included in the analysis. We measured a main effect of PDI-21scores on belief flexibility measured with MADS. PDI-21 Conviction scores predicted outcomes for all measured MADS items. Increasing PDI Distress and Preoccupation scores were predictors for being more likely to dismiss beliefs and change conviction. Time itself was a predictor for changing conviction and being able to plan a behavioral experiment. Overall the changes in PDI scores predicted outcomes for belief flexibility measured with MADS items. The PDI-21 could be a simple and effective way to measure progress in treatment on delusional beliefs.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–23.
Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169–79.
Garety PA, Freeman D, Jolley S, Dunn G, Bebbington PE, Fowler DG, et al. Reasoning, emotions, and delusional conviction in psychosis. J Abnorm Psychol. 2005;114(3):373–84.
Ward T, Garety PA. Fast and slow thinking in distressing delusions: a review of the literature and implications for targeted therapy. Schizophr Res. 2019;203:80–7.
Wessely S, Buchanan A, Reed A, Cutting J, Everitt B, Garety P, et al. Acting on delusions. I: prevalence. Br J Psychiatry. 1993;163(01):69–76.
Zhu C, Sun X, So SH. Associations between belief inflexibility and dimensions of delusions: a meta-analytic review of two approaches to assessing belief flexibility. Br J Clin Psychol. 2018;57(1):59–81.
Brabban A, Tai S, Turkington D. Predictors of outcome in brief cognitive behavior therapy for schizophrenia. Schizophr Bull. 2009;35(5):859–64.
Verdoux H, Maurice-Tison S, Gay B, Os JV, Salamon R, Bourgeois ML. A survey of delusional ideation in primary-care patients. Psychol Med. 1998;28(1):127–34.
So SH, Peters ER, Swendsen J, Garety PA, Kapur S. Changes in delusions in the early phase of antipsychotic treatment – an experience sampling study. Psychiatry Res. 2014;215(3):568–73.
Mehl S, Werner D, Lincoln TM. Does cognitive behavior therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Front Psychol [Internet]. 2015[cited 2019 Apr 24];6. Available from: http://journal.frontiersin.org/Article/10.3389/fpsyg.2015.01450/abstract.
Lincoln TM, Rief W, Westermann S, Ziegler M, Kesting M-L, Heibach E, et al. Who stays, who benefits? Predicting dropout and change in cognitive behaviour therapy for psychosis. Psychiatry Res. 2014;216(2):198–205.
Khazaal Y, Chatton A, Dieben K, Huguelet P, Boucherie M, Monney G, et al. Reducing delusional conviction through a cognitive-based group training game: a multicentre randomized controlled trial. Front Psych [Internet]. 2015 [cited 2019 Apr 24];6. Available from: http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00066/abstract.
Khazaal Y, Favrod J, Azoulay S, Finot SC, Bernabotto M, Raffard S, et al. “Michael’s game,” a card game for the treatment of psychotic symptoms. Patient Educ Couns. 2011;83(2):210–6.
Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64(6):663–7.
Shafer A. Meta-analysis of the brief psychiatric rating scale factor structure. Psychol Assess. 2005;17(3):324–35.
Pichot P, Samuel-Lajeunesse B, Lebreaux AM. A new experimenatl form of BPRS. Ann Med Psychol (Paris). 1973;2(2):254–63.
Sullivan Pepe M, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Commun Stat - Simul Comput. 1994;23(4):939–51.
Peters E, Joseph S, Day S, Garety P. Measuring delusional ideation: the 21-item Peters et al. delusions inventory (PDI). Schizophr Bull. 2004;30(4):1005–22.
We thank the participants and the game leaders, as well as Karen Dieben, Gregoire Monney, Virginie Salamin, Dr. Fethi Bretel, Silke Azoulay, Elodie Pesenti, Raoul Krychowski, Andreia Costa Prata, Dr. Alexei Traian, Dr. Thomas Charpeaud, Prof. Daniele Zullino, Prof. Alberto Parabiaghi, Joanne Corpataux, Milena Kriz, Dr. Giacomini, Claude Hayoz (Fondation HorizonSud), Dr. Georges Klein, Phillippe Laffond, Prof. Eric Bonvin, Prof. Sonia Dollfus, Prof. Thierry D’Amato, Prof. Jean-Michel Llorca, Dr. George Berthon, Dr. Céline Plassereaud, Dr. Véronique Roure, Natacha Boureykoff, Marie-Josée Durak, Dr. Maria Teresa Caldera, Dr. Roberta Bossoletti, and Dario Caffaro. Funding: Swiss National Science Foundation Grant 32003B-121038.
Disclosure of Potential Conflicts of Interest
This study was funded by Swiss National Science Foundation Grant 32003B-121038. Yasser Khazaal and Jérôme Favrod are the authors of the game. The other co-authors declare that the research was conducted in the absence of any commercial or financial relationships that could be conceived as a potential conflict of interest.
Research Involving Human Participants and/or Animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committees. The ethical committees of all four countries approved the trial. The protocol was registered (International Standard Randomized Controlled Trial Number Register: ISRCTN37178153) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Penzenstadler, L., Chatton, A., Huguelet, P. et al. Does Change over Time in Delusional Beliefs as Measured with PDI Predict Change over Time in Belief Flexibility Measured with MADS?. Psychiatr Q 90, 693–702 (2019). https://doi.org/10.1007/s11126-019-09659-8
- Delusional beliefs
- Belief flexibility
- Cognitive behavior therapy